Full Papers
What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective
M.C. Hochberg
CER1975
2001 Vol.19, N°6 ,Suppl.25
PI 0015, PF 0022
Full Papers
Free to view
(click on article PDF icon to read the article)
